Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irene Urciuoli has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Weight Loss and Sleep, Current Evidence in Animal Models and Humans

    by Elena Gangitano, Noelia Martinez-Sanchez, Maria Irene Bellini, Irene Urciuoli, Stefania Monterisi, Stefania Mariani, David Ray, Lucio Gnessi

    Sleep is a vital process essential for survival. The trend of reduction in the time dedicated to sleep has increased in industrialized countries, together with the dramatic increase in the prevalence of obesity and diabetes. Short sleep may increase the risk of obesity, diabetes and cardiovascular disease, and on the other hand, obesity is associated with sleep disorders, such as obstructive apnea disease, insomnia and excessive daytime sleepiness. Sleep and metabolic disorders are linked; therefore, identifying the physiological and molecular pathways involved in sleep regulation and metabolic homeostasis can play a major role in ameliorating the metabolic health of the individual. Approaches aimed at reducing body weight could provide benefits for both cardiometabolic risk and sleep quality, which indirectly, in turn, may determine an amelioration of the cardiometabolic phenotype of individuals. We revised the literature on weight loss and sleep, focusing on the mechanisms and the molecules that may subtend this relationship in humans as in animal models.


  • Open Access

    Intracholecystic versus Intravenous Indocyanine Green (ICG) Injection for Biliary Anatomy Evaluation by Fluorescent Cholangiography during Laparoscopic Cholecystectomy: A Case–Control Study

    by Lidia Castagneto-Gissey, Maria Francesca Russo, Alessandra Iodice, James Casella-Mariolo, Angelo Serao, Andrea Picchetto, Giancarlo D’ambrosio, Irene Urciuoli, Alessandro De Luca, Bruno Salvati, et al.

    (1) Background: Fluorescence cholangiography has been proposed as a method for improving the visualization and identification of extrahepatic biliary anatomy in order to possibly reduce injuries and related complications. The most common method of indocyanine green (ICG) administration is the intravenous route, whereas evidence on direct ICG injection into the gallbladder is still quite limited. We aimed to compare the two different methods of ICG administration in terms of the visualization of extrahepatic biliary anatomy during laparoscopic cholecystectomy (LC), analyzing differences in the time of visualization, as well as the efficacy, advantages, and disadvantages of both modalities. (2) Methods: A total of 35 consecutive adult patients affected by acute or chronic gallbladder disease were enrolled in this prospective case–control study. Seventeen patients underwent LC with direct gallbladder ICG injection (IC-ICG) and eighteen subjects received intravenous ICG administration (IV-ICG). (3) Results: The groups were comparable with regard to their demographic and perioperative characteristics. The IV-ICG group had a significantly shorter overall operative time compared to the IC-ICG group (p = 0.017). IV-ICG was better at delineating the duodenum and the common hepatic duct compared to the IC-ICG method (p = 0.009 and p = 0.041, respectively). The cystic duct could be delineated pre-dissection in 76.5% and 66.7% of cases in the IC-ICG and IV-ICG group, respectively, and this increased to 88.2% and 83.3% after dissection. The common bile duct could be highlighted in 76.5% and 77.8% of cases in the IC-ICG and IV-ICG group, respectively. Liver fluorescence was present in one case in the IC-ICG group and in all cases after IV-ICG administration (5.8% versus 100%; p < 0.0001). (4) Conclusions: The present study demonstrates how ICG-fluorescence cholangiography can be helpful in identifying the extrahepatic biliary anatomy during dissection of Calot’s triangle in both administration methods. In comparison with intravenous ICG injection, the intracholecystic ICG route could provide a better signal-to-background ratio by avoiding hepatic fluorescence, thus increasing the bile duct-to-liver contrast.


  • Robotic versus open pancreaticoduodenectomy: Is there any difference for frail patients?

    by Claudia Paolini, Lapo Bencini, Linda Gabellini, Irene Urciuoli, Sabrina Pacciani, Angela Tribuzi, Luca Moraldi, Massimo Calistri, Andrea Coratti


  • Robotic pancreatic surgery: minimally invasive approach to challenging operations

    by Lapo Bencini, Irene Urciuoli, Martina Trafeli, Claudia Paolini, Luca Moraldi, Angela Tribuzi, Sabrina Pacciani, Andrea Coratti

    Article: Robotic pancreatic surgery: minimally invasive approach to challenging operations - Minerva Surgery 2021 April;76(2):138-45 - Minerva Medica - Journals


  • Robotic Versus Laparoscopic Partial Mesorectal Excision for Cancer of the High Rectum: A Single‐Center Study with Propensity Score Matching Analysis

    by Nicola De'ANgelis, Margerita Notarnicola, Aleix Martínez‐Pérez, Riccardo Memeo, Cecile Charpy, Irene Urciuoli, Fabio Maroso, Daniele Sommacale, Aurelien Amiot, Florence Canouï‐Poitrine, et al.

    Background: The role of robotic surgery for partial mesorectal excision (PME) in patients with high rectal cancer (RC) remains unexplored. This study aimed to compare the operative and postoperative outcomes of robotic (R‐PME) versus laparoscopic (L‐PME) PME for high RC.Methods: This was a single‐center propensity score cohort study of consecutive patients diagnosed with RC in the high rectum (>10 to 15 cm from the anal verge) who underwent surgery between September 2012 and May 2019.Results: Of 131 selected patients (50 R‐PME and 81 L‐PME), 88 were matched using propensity score (44 per group). Operative and postoperative variables were similar between R‐PME and L‐PME patients, except for operative time (220 min and 190 min, respectively; p < 0.0001). No conversion was needed. Overall morbidity was 15.9%; 4 patients (4.5%) developed anastomotic leakage. The mean hospital stay was 7.25 days for R‐PME vs. 7.64 days for L‐PME (p = 0.597). R0 resection was achieved in 100% of R‐PME and 90.9% of L‐PME (p = 0.116). Only 3 patients (1 R‐PME, 2 L‐PME) received a permanent stoma (p = 1). No group differences were observed for overall or disease‐free survival rates at 5 years. The costs of R‐PME were significantly higher than those of L‐PME.Conclusion: Minimally invasive surgery can be performed safely for PME in high RC. No difference can be detected between R‐PME and L‐PME for both short‐ and long‐term outcomes, leaving the choice of the surgical approach to the surgeon's experience. Specific health economic studies are needed to evaluate the cost‐effectiveness of robotic surgery for RC.


  • Extensive lethal gas diffusion complicating a ‘benign’ disease

    by Hassen Hentati, Niccolò Petrucciani, Irene Urciuoli, Nicola De'ANgelis, Tarek Naanaa, Haythem Najah